Recent Finacing
Recent Raise
Synpromics develops synthetic promoters via PromPT™ platform to design DNA regulatory sequences controlling gene expression for gene therapy, cell therapy, gene editing; partners with gene therapy and bioprocessing firms.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors